Obesity-related alterations in plasma metabolomics and fecal microbiota in Down syndrome Dp(16)1Yey mice

Abstract Background/objectives Individuals with Down syndrome (DS) are at increased risk of obesity and metabolic comorbidities, yet the mechanisms underlying these conditions remain unclear. Here we investigated how DS-associated genetic condition interacts with diet and metabolic pathways in the Dp(16)1Yey mouse model of DS. Methods Untargeted plasma metabolomics was performed in Dp(16)1Yey and control mice, subjected to either control (CTL) or high-fat diet (HFD). Raw data were processed, and features were annotated. Statistical analyses were conducted in R, and pathway analysis was performed with MetaboAnalyst v5.0. Fecal microbiome composition was profiled by 16S rRNA amplicon sequencing and analyzed using phyloseq in R. Results Diet exerted the strongest effect on mice plasma metabolome, followed by sex and genotype. Seventy-five diet-responsive metabolites were enriched in amino acid and nucleotide metabolism. Genotype-driven changes affected 34 metabolites, notably impacting amino acid and taurine–hypotaurine metabolism. Fifty-six sex-associated metabolites highlighted disruptions in aromatic amino acid biosynthesis and pyrimidine metabolism. A significant Diet*Genotype interaction was observed for five metabolites, including a marked reduction in the microbiota-derived metabolite 3-indolepropionic acid (IPA) in Dp(16)1Yey mice on HFD. Both genotype and diet exerted pronounced effects on fecal microbiome with selective depletion of the Clostridia OTU_160 (unknown Lachnospiraceae ) in Dp1Yey mice under HFD conditions, which correlated with peripheral IPA levels. Conclusion Segmental trisomy in Dp(16)1Yey mice modulates the host metabolic response to dietary fat, partly through microbiota-derived metabolites such as IPA. These findings highlight the importance of genotype, diet, and microbiome interactions in shaping metabolic disease risk in DS and point toward microbiota-targeted dietary interventions.

Authors

Institutions

Publication Details

Journal
Cellular and Molecular Life Sciences
Published
2026-09-11
DOI
https://doi.org/10.1007/s00018-026-06403-x
Primary Topic
Down syndrome and intellectual disability research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Obesity-related alterations in plasma metabolomics and fecal microbiota in Down syndrome Dp(16)1Yey mice

Guillaume Pavlovic, Farid Ichou, Pinku Halder, Laura Desnouveaux et al.
Cellular and Molecular Life Sciences
Down syndrome and intellectual disability research
article

Obesity-related alterations in plasma metabolomics and fecal microbiota in Down syndrome Dp(16)1Yey mice

Guillaume Pavlovic, Farid Ichou, Pinku Halder, Laura Desnouveaux, Loïc Lindner, Marie‐Claude Potier, Mohammed Selloum, Yann Hérault, Francois-Xavier Lejeune
article en

Abstract

Abstract Background/objectives Individuals with Down syndrome (DS) are at increased risk of obesity and metabolic comorbidities, yet the mechanisms underlying these conditions remain unclear. Here we investigated how DS-associated genetic condition interacts with diet and metabolic pathways in the Dp(16)1Yey mouse model of DS. Methods Untargeted plasma metabolomics was performed in Dp(16)1Yey and control mice, subjected to either control (CTL) or high-fat diet (HFD). Raw data were processed, and features were annotated. Statistical analyses were conducted in R, and pathway analysis was performed with MetaboAnalyst v5.0. Fecal microbiome composition was profiled by 16S rRNA amplicon sequencing and analyzed using phyloseq in R. Results Diet exerted the strongest effect on mice plasma metabolome, followed by sex and genotype. Seventy-five diet-responsive metabolites were enriched in amino acid and nucleotide metabolism. Genotype-driven changes affected 34 metabolites, notably impacting amino acid and taurine–hypotaurine metabolism. Fifty-six sex-associated metabolites highlighted disruptions in aromatic amino acid biosynthesis and pyrimidine metabolism. A significant Diet*Genotype interaction was observed for five metabolites, including a marked reduction in the microbiota-derived metabolite 3-indolepropionic acid (IPA) in Dp(16)1Yey mice on HFD. Both genotype and diet exerted pronounced effects on fecal microbiome with selective depletion of the Clostridia OTU_160 (unknown Lachnospiraceae ) in Dp1Yey mice under HFD conditions, which correlated with peripheral IPA levels. Conclusion Segmental trisomy in Dp(16)1Yey mice modulates the host metabolic response to dietary fat, partly through microbiota-derived metabolites such as IPA. These findings highlight the importance of genotype, diet, and microbiome interactions in shaping metabolic disease risk in DS and point toward microbiota-targeted dietary interventions.

Cellular and Molecular Life Sciences
Centre National de la Recherche Scientifique (FR), Inserm (FR), Sorbonne Université (FR), Institut de génétique et de biologie moléculaire et cellulaire (FR), Assistance Publique – Hôpitaux de Paris (FR), Pitié-Salpêtrière Hospital (FR), Phénotypage et ingénierie précliniques des systèmes d’organismes modèles (FR), Institut du Cerveau (FR), Fondation pour l’innovation en Cadiométabolisme et Nutrition (FR), Sage (United Kingdom) (GB)
Agence Nationale de la Recherche, H2020 European Research Council
Good health and well-being
Openalex Percentile: Top 8%
Down syndrome and intellectual disability research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.